Implementation of an Absolute Brain $^{1}$H-MRS Quantification Method to Assess Different Tissue Alterations in Multiple Sclerosis

Magnetic resonance spectroscopy has emerged as a sensitive modality to detect early and diffuse alterations in multiple sclerosis. Recently, the hypothesis of neurodegenerative pathogenesis has highlightened the interest for measurement of metabolites concentrations, to gain specificity, in a large brain volume encompassing different tissue alterations. Therefore, we proposed in this paper the implementation of an absolute quantification method based on localized spectroscopy at short (30 ms) and long (135 ms) echo time of a volume including normal appearing white matter, cortical gray matter, and lesions. First, methodological developments were implemented including external calibration, and corrections of phased-array coil sensitivity and cerebrospinal fluid volume contribution. Second, these improvements were validated and optimized using an original methodology based on simulations of brain images with lesions. Finally, metabolic alterations were assessed in 65 patients including 26 relapsing-remitting, 17 primary-progressive (PP), 22 secondary-progressive (SP) patients, and in 23 normal subjects. Results showed increases of choline, creatine, and myo-inositol concentrations in PP and SP patients compared to controls, whereas the concentration of N-acetyl compounds remained constant. The major finding of this study was the identification of Cho concentration and Cho/tNA ratio as putative markers of progressive onset, suggesting interesting perspectives in detection and followup of neurodegenerative processes.

[1]  L. Krupp,et al.  Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy , 2002, Multiple sclerosis.

[2]  M. Bagory,et al.  "Absolute" quantification in Magnetic Resonance Spectroscopy: validation of a clinical protocol in multiple sclerosis , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[3]  Klaas Nicolay,et al.  1H MR spectroscopy of the brain: absolute quantification of metabolites. , 2006, Radiology.

[4]  Zografos Caramanos,et al.  1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. , 2005, Brain : a journal of neurology.

[5]  C H Polman,et al.  MR spectroscopic evidence for glial increase but not for neuro‐axonal damage in MS normal‐appearing white matter , 2005, Magnetic resonance in medicine.

[6]  D. Arnold,et al.  Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis , 2002, Journal of Neurology.

[7]  S. M. Steve SUSAN - a new approach to low level image processing , 1997 .

[8]  Jullie W Pan,et al.  Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation , 1996, Magnetic resonance in medicine.

[9]  Hristian,et al.  RELAPSES AND PROGRESSION OF DISABILITY IN MULTIPLE SCLEROSIS , 2000 .

[10]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[11]  D. Graveron-Demilly,et al.  Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[12]  R I Grossman,et al.  Total brain N-acetylaspartate , 2000, Neurology.

[13]  M. Sdika,et al.  Time‐domain semi‐parametric estimation based on a metabolite basis set , 2005, NMR in biomedicine.

[14]  J. Frahm,et al.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.

[15]  Oded Gonen,et al.  Diffusely elevated cerebral choline and creatine in relapsing‐remitting multiple sclerosis , 2003, Magnetic resonance in medicine.

[16]  Antonio Federico,et al.  Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis , 2005, Journal of the Neurological Sciences.

[17]  D. Leibfritz,et al.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.

[18]  U Klose,et al.  Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. , 2001, Brain : a journal of neurology.

[19]  R. Kreis Quantitative localized 1H MR spectroscopy for clinical use , 1997 .

[20]  Zografos Caramanos,et al.  Axonal metabolic recovery in multiple sclerosis patients treated with interferon β–1b , 2001, Journal of Neurology.

[21]  P M Matthews,et al.  Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. , 2001, Archives of neurology.

[22]  C. Elster,et al.  Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-β therapy on absolute metabolite concentrations , 2002, Magnetic Resonance Materials in Physics, Biology and Medicine.

[23]  P. Narayana,et al.  Compensation for surface coil sensitivity variation in magnetic resonance imaging. , 1988, Magnetic resonance imaging.

[24]  O. Khan,et al.  Long‐Term Study of Brain 1H‐MRS Study in Multiple Sclerosis: Effect of Glatiramer Acetate Therapy on Axonal Metabolic Function and Feasibility of Long‐Term 1H‐MRS Monitoring in Multiple Sclerosis , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[25]  J. Babb,et al.  Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations. , 2002, Radiology.

[26]  Stephen K Fisher,et al.  Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance , 2002, Journal of neurochemistry.

[27]  L L Wald,et al.  Proton spectroscopic imaging of the human brain using phased array detectors , 1995, Magnetic resonance in medicine.

[28]  P. Kingsley,et al.  Saturation‐corrected T 1 and T 2 relaxation times of choline, creatine and N‐acetyl aspartate in human cerebral white matter at 1.5 T , 2003, NMR in biomedicine.

[29]  Gregor Jost,et al.  Quantitative single‐voxel spectroscopy: The reciprocity principle for receive‐only head coils , 2005, Journal of magnetic resonance imaging : JMRI.

[30]  André Briguet,et al.  Product-Operator Algebra for Strongly Coupled Spin Systems , 1993 .

[31]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[32]  P. Roemer,et al.  The NMR phased array , 1990, Magnetic resonance in medicine.

[33]  G Helms,et al.  Volume correction for edema in single‐volume proton MR spectroscopy of contrast‐enhancing multiple sclerosis lesions , 2001, Magnetic resonance in medicine.

[34]  G J Barker,et al.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.

[35]  Oded Gonen,et al.  Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. , 2003, Magnetic resonance imaging.

[36]  H. Rusinek,et al.  MR spectroscopy indicates diffuse multiple sclerosis activity during remission , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[37]  A. Evans,et al.  MRI simulation-based evaluation of image-processing and classification methods , 1999, IEEE Transactions on Medical Imaging.

[38]  S. Vukusic,et al.  Natural history of multiple sclerosis: a unifying concept. , 2006, Brain : a journal of neurology.

[39]  A. Thompson,et al.  Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.

[40]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  Michael Erb,et al.  Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla , 2003, Magnetic resonance in medicine.

[42]  D. Louis Collins,et al.  Design and construction of a realistic digital brain phantom , 1998, IEEE Transactions on Medical Imaging.

[43]  S. Confort-Gouny,et al.  Optimization of residual water signal removal by HLSVD on simulated short echo time proton MR spectra of the human brain. , 2001, Journal of magnetic resonance.

[44]  B. Agranoff,et al.  Differentiated Human NT2‐N Neurons Possess a High Intracellular Content of myo‐Inositol , 1999, Journal of neurochemistry.

[45]  Yoshio Hiraki,et al.  Development of a tissue‐equivalent MRI phantom using carrageenan gel , 2003, Magnetic resonance in medicine.

[46]  F. Barkhof The clinico‐radiological paradox in multiple sclerosis revisited , 2002, Current opinion in neurology.

[47]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[48]  P M Matthews,et al.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.

[49]  J. Frahm,et al.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.